This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Philips Collaborates With Accenture To Create First Proof Of Concept For Delivering Vital Patient Data Via Google Glass

ANDOVER, Mass. and NEW YORK, Oct. 3, 2013 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) and Accenture (NYSE: ACN) today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information.

The new concept demonstration depicts how a doctor wearing the display could simultaneously monitor a patient's vital signs and react to surgical procedural developments without having to turn away from the patient or procedure. A physician could also monitor a patient's vital signs remotely or enlist assistance from doctors in other locations.

"We live in a world where being nimble is key and industry-altering ideas need to be converted to practical solutions that people can use," said Michael Mancuso, CEO, Patient Care and Clinical Informatics at Philips Healthcare. "This research explores how doctors can achieve better access to the right information at the right time so they can focus on more efficient and effective patient care. It's a first step in researching how existing technologies can be applied to improve the quality of life of patients."

Researchers from Philips' newly created 'Digital Accelerator Lab,' a cross-sector innovation platform with labs based in the Netherlands and India, collaborated with researchers from Accenture Technology Labs to explore the potential use of Google Glass in clinical settings. The goal was to create the first proof of concept for Google Glass and Philips IntelliVue Solutions and then to begin exploring additional opportunities to integrate Google Glass seamlessly with Philips healthcare solutions.

"Accenture's work with Philips showcases a powerful use of wearable devices in the healthcare industry, helping physicians perform their jobs more effectively and enhancing care for patients," said Paul Daugherty, chief technology officer, Accenture. "This exciting work highlights the potential of digital technologies to transform the way we work and live, and we're pleased to have collaborated with Philips to help bring this vision to life."

Aside from the possibility of operating in a hands-free environment, the Google Glass IntelliVue Solution research effort was developed to explore how to enhance a clinician's mobility by allowing the seamless transfer of patient information while on the go. Further research may indicate how to possibly enable clinicians to keep their focus on the patient while simultaneously obtaining a live view of critical patient monitoring data.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs